Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5231-5240 Newer>

The Motley Fool November 11, 2008 Brian Orelli	Two Years of Red Aesthetic laser makers have been rocked over the last few years.
The Motley Fool November 11, 2008 Brian Orelli	AOB Is A-OK Growing through acquisitions seems to be working.
The Motley Fool November 10, 2008 Brian Orelli	Drug Fuels an Idling Rocket Ship AstraZeneca needs another FDA approval to really take advantage of its cholesterol drug's success.
The Motley Fool November 7, 2008 Brian Orelli	Onyx -- Still Waiting Onyx licenses a pre-clinical drug from England's BTG International -- but it's got a new problem to worry about.
The Motley Fool November 7, 2008 Brian Orelli	Teva's Steady Growth Generic-drug maker Teva Pharmaceuticals has been a good defensive play during the severe downturn in the market.
The Motley Fool November 7, 2008 Brian Orelli	Thinning Out the Pipeline The FDA says no to diet drugs from Sanofi-Aventis and Pfizer.
The Motley Fool November 7, 2008 Brian Orelli	Will Obama Make Your Portfolio Healthy? The changes coming in the health-care industry could be a mixed bag of good and bad for your portfolio.
The Motley Fool November 5, 2008 Brian Orelli	A Byetta Beating The FDA gives Amylin and Alkermes a smack down, but neither company is knocked out yet.
The Motley Fool November 5, 2008 Brian Orelli	ZymoGenetics Leads With Its Chin It says a lot about ZymoGenetics' quarter that management decided to open its conference call talking about its hepatitis C drug still in trials, rather than the sales results of its blood-clotting agent, Recothrom.
The Motley Fool November 4, 2008 Brian Orelli	Does the Supreme Court Control Your Investment? The Supreme Court is about to make a decision that could affect drug company investors.
<Older 5231-5240 Newer> Return to current articles.